4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol,
Kryptosterol,
Lanosterol,
lanosterol,
79-63-0,
Lanosterin,
Lanster,
Botalan base 138,
Lanosta-8,24-dienol,
(3beta)-lanosta-8,24-dien-3-ol,
Lanosta-8,24-dien-3beta-ol,
UNII-1J05Z83K3M,
NSC60677,
Botalan base,
CHEBI:16521,
CAHGCLMLTWQZNJ-BQNIITSRSA-N,
Lanosta-8,24-dien-3.beta.-ol,
1J05Z83K3M,
MFCD00021108,
Lanostadien-3-beta-ol,
NSC 60677,
Lanosta-8,24-dien-3-ol, (3beta)-,
Lanosta-8,24-dien-3-ol,
Lanosta-8,24-dien-3-ol, (3.beta.)-,
Lanosta-8,24-dien-3-beta-ol,
4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol,
EINECS 201-214-9,
Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-,
(3-beta)-Lanosta-8,24-dien-3-ol,
BRN 2226449,
(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol,
AI3-23643,
Lanostereol,
Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3beta,5alpha)-,
(3.beta.)-Lanosta-8,24-dien-3-ol,
Lanosta-8,24-dien-3-ol, (3-beta)-,
AC1L6JAE,
8,24-Lanostadien-3beta-ol,
Lanosta-8, (3.beta.)-,
8,24-Lanostadien-3|A-ol,
Lanosterol, >=93%, powder,
SCHEMBL145834,
CHEMBL225111,
GTPL2746,
DTXSID1040744,
3|A-Hydroxy-8,24-lanostadiene,
3beta-Hydroxy-8,24-lanostadiene,
ZINC3870056,
LMST01010017,
NSC-60677,
(3 beta)-Lanosta-8,24-dien-3-ol,
AKOS024307002,
DB03696,
HY-W020033,
Lanosta-8,24-dien-3beta-ol (8CI),
MCULE-6692951185,
NCGC00164398-01,
(3beta,20R)-Lanosta-8,24-dien-3-ol,
CS-0031956,
FT-0627682,
7073-EP2277507A1,
7073-EP2286795A1,
7073-EP2298776A1,
C01724,
(3alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol,
(3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol,
4,4,14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol,
C4CA2F34-1C1A-4673-AC43-E547708CB228,
Cholesta-8, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-,
UNII-U431865SO1 component CAHGCLMLTWQZNJ-BQNIITSRSA-N,
(3beta,5alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol,
(3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol,
(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol,
Kryptosterol,
Cryptosterol,
Euphadienol,
lanosterol-,
lanosterol 50-60%,
D0P4PQ,
C30H50O,
c0427,
C30-H50-O,
CID246983,
4-06-00-04188 (Beilstein Handbook Reference),
D007810,
4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol,
LAN,